Sign in

CIK 0001640266 · Accelerated filer<br>Smaller reporting company

Voyager Therapeutics, Inc.

Sign in to watch
Ticker
VYGR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
857-259-5340
Business address
75 HAYDEN AVENUE, LEXINGTON, MA, 02421
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-06-03 PIERCE GLENN Director Grant or award · Stock Option (Right to Buy) +24,000 24,000
2025-06-03 Onyia Jude Director Grant or award · Stock Option (Right to Buy) +24,000 24,000
2025-06-03 MACKEY CATHERINE J Director Grant or award · Stock Option (Right to Buy) +24,000 24,000
2025-06-03 Hyman Steven Director Grant or award · Stock Option (Right to Buy) +24,000 24,000
2025-06-03 Higgins Michael J Director Grant or award · Stock Option (Right to Buy) +24,000 24,000
2025-06-03 GERAGHTY JAMES A Director Grant or award · Stock Option (Right to Buy) +24,000 24,000
2025-06-03 Colon Grace Director Grant or award · Stock Option (Right to Buy) +24,000 24,000
2025-04-02 Ferguson Toby Chief Medical Officer Sale −10,086 $3.43 $35K 157,914
2025-04-02 Sandrock Alfred President and CEO Sale −10,885 $3.43 $37K 430,931
2025-02-21 Carter Todd Alfred Chief Scientific Officer Grant or award +46,000 123,718
2025-02-21 Carter Todd Alfred Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +92,000 92,000
2025-02-21 Sandrock Alfred President and CEO Grant or award +145,000 441,816
2025-02-21 Sandrock Alfred President and CEO Grant or award · Stock Option (Right to Buy) +290,000 290,000
2025-02-21 Swartz Robin COO & CBO Grant or award +71,250 169,647
2025-02-21 Swartz Robin COO & CBO Grant or award · Stock Option (Right to Buy) +142,500 142,500
2025-02-21 Fahey Sandell Jacquelyn Chief Legal Officer Grant or award +41,500 123,143
2025-02-21 Fahey Sandell Jacquelyn Chief Legal Officer Grant or award · Stock Option (Right to Buy) +83,000 83,000
2025-02-21 Ferguson Toby Chief Medical Officer Grant or award +63,000 168,000
2025-02-21 Ferguson Toby Chief Medical Officer Grant or award · Stock Option (Right to Buy) +126,000 126,000
2025-02-21 Jorgensen Nathan D. Chief Financial Officer Grant or award +51,500 131,500

Page 3 of 7 · 130 trades